Association of Germline Variant Status With Therapy Response in High-risk Early-Stage Breast Cancer

Volume: 6, Issue: 5, Pages: 744 - 744
Published: May 1, 2020
Abstract

Importance

The GeparOcto randomized clinical trial compared the efficacy of 2 neoadjuvant breast cancer (BC) treatment regimens: sequential intense dose-dense epirubicin, paclitaxel, and cyclophosphamide (iddEPC) vs weekly paclitaxel and nonpegylated liposomal doxorubicin (PM) in patients with different biological BC subtypes. Patients with triple-negative BC (TNBC) randomized to the PM arm received additional carboplatin (PMCb)....
Paper Details
Title
Association of Germline Variant Status With Therapy Response in High-risk Early-Stage Breast Cancer
Published Date
May 1, 2020
Volume
6
Issue
5
Pages
744 - 744
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.